#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colon cancer Gastrointestinal stromal tumour Malignant peritoneal neoplasm Niemann-Pick disease Hereditary spastic paraplegia Hepatocellular carcinoma Henoch-Schonlein purpura Acute graft versus host disease in liver Primary immunodeficiency syndrome Autoimmune hepatitis Penile cancer Fibrous dysplasia of bone Non-renal cell carcinoma of kidney Angiosarcoma non-metastatic Nephroblastoma More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Basic Information Toxic epidermal necrolysis – Treatment Haemophagocytic lymphohistiocytosis – Trials in Disease Epidermolysis bullosa Small intestine leiomyosarcoma – Life with Disease IgA nephropathy – Basic Information Langerhans’ cell histiocytosis – Treatment Lymphangiosarcoma – Life with Disease Mucopolysaccharidosis III – Basic Information Niemann-Pick disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VX-407 PETHIDINE HYDROCHLORIDE Mercaptamine Giredestrant LTI-03 USNOFLAST Belzutifan Leuprorelin Odm-111 Bosentan Molgramostim Adalimumab GSKVX000000039711 Sodium Thiosulfate Art6043 Ladarixin Cabotegravir Sodium Benfotiamine Mosaic Hbcoreag Al8326 More therapies…

    Learn about Your Condition

    Urticaria cholinergic Sepsis Osteomyelitis acute Hepatic cirrhosis Meniscus operation Trisomy 21 Turner's syndrome Lymphoma Ovarian cancer stage IV Lymphoedema Methylmalonic acidaemia Eyelid ptosis Mucopolysaccharidosis Pancreatic neoplasm Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    France Germany Greece Italy The Netherlands Poland +1

  • Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Tildrakizumab
    • Etanercept
    Hungary Poland Slovakia Spain

  • Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Apremilast
    France

  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Mdna11
    • Pembrolizumab
    Ireland Poland Portugal Spain

  • Study on the Long-term Safety of Guselkumab for Children with Crohn’s Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    Belgium France Germany Italy Norway Poland +2

  • Study on Autologous Skin-Derived Keratinocytes and Fibroblasts for Patients with Basal Cell Carcinoma Undergoing Reconstructive Surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Micrographic skin surgery
    Investigated Drugs:
    • Autologous Skin-Derived Adult Fibroblasts Expanded
    • Autologous Skin-Derived Adult Keratinocytes Expanded
    • Skin Autograft
    Spain
Previous Page
1 … 16 17 18 19 20 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!